// App-Quantinova.ai

ABS163 : PREDICTIVE MODELLING IDENTIFIES RESPONSE TO FIXED DOSE N8‐GP PROPHYLAXIS IN THE FIRST WEEKS OF TREATMENT AS A PREDICTOR OF LONG‐TERM OUTCOMES

Researchers

Presenter

  • P. Chowdary

Principal Investigators

  • S. Benchikh El Fegoun

  • M. S. Geybels

  • A. Tiede

Medical Centers

  • The Royal Marsden Hospital, London, United Kingdom

  • Novo Nordisk Health Care A/S, Zurich, Switzerland

  • Novo NordiskA/S, Soborg, Denmark

  • Hannover Medical School, Hannover, Germany

Locations

  • United Kingdom

  • Switzerland

  • Denmark

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Fixed Dose

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved